Adam P. Samansky

Adam P. Samansky — Patent Litigation Practice Summary

Specialty / focus areas. Samansky is an intellectual property litigator and Member (partner) in Mintz's Boston office, handling patent, trademark, and trade secret disputes for pharmaceutical, medical, high-tech, and defense-industry clients. His core strength is Hatch-Waxman/ANDA pharmaceutical litigation, with additional patent work across biochemistry, polymers, optics, electronics/communications, medical devices, and mechanical technologies (per his Mintz bio and National Law Review author profile).

Side preference. His tracked docket is defense-side: one appearance, as defendant-side lead counsel at Mintz Levin (0 plaintiff / 1 defendant). That aligns with much of his recent work defending operating companies — Teva in multiple ANDA cases, Igloo Products, SimpliSafe, Polymer Logistics, and Medivators, including NPE suits (e.g., Wireless Monitoring Systems v. SimpliSafe; Tangelo IP v. TigerDirect, both E.D. Tex.). However, he also prosecutes for patent owners and innovators (Kowa, Philips, Straight Path IP Group, WePower), so the practice is genuinely two-sided with a defense-leaning recent docket.

Firm context and notable cases. He began at Edwards Angell Palmer & Dodge, became a partner at its successor Edwards Wildman Palmer (2004–2014), then joined Mintz Levin, where he leads the firm's IP practice in Israel. Notable matters include Kowa Pharmaceuticals v. Amneal (Livalo®/pitavastatin): he presented the plaintiff's infringement case at a 10-day trial won on all issues, affirmed by the Federal Circuit; Jazz Pharmaceuticals v. Teva, Evoke Pharma v. Teva, and Horizon Medicines v. Teva (defense of Teva in ANDA litigations); Takeda v. Alphapharm, 492 F.3d 1350 (Fed. Cir. 2007), a leading post-KSR chemical obviousness decision; and Wellman v. Eastman Chem., where he secured a Federal Circuit reversal of an indefiniteness ruling.

PTAB/IPR, bar, education. He has a genuine IPR/PGR practice: successful preliminary responses defeating institution (three IPRs in the Kowa matter; one for RAD Data Communications), appellate work on PTAB final written decisions (e.g., Green Cross v. Shire, Fed. Cir. No. 17-2071), and assistance on Straight Path IP Group v. Sipnet EU, the first Federal Circuit decision to reverse a PTAB IPR decision in its entirety. Admitted Massachusetts (2004) and New York (2011), plus the Federal Circuit, First Circuit, U.S. Supreme Court, and multiple district courts. Education: B.A., Brandeis University (2000); J.D., Suffolk University Law School (2004).